The use of low-dose WBCT in multiple myeloma provided important information that helped guide patient management in 97% of the cases that were reviewed.
from Latest articles from Cancer Therapy Advisor News https://ift.tt/2N4SzEk
from Latest articles from Cancer Therapy Advisor News https://ift.tt/2N4SzEk